The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Swiedler Stuart J since 2005.
The trader's CIK number is 1312510.
At the time of the last reporting, Swiedler Stuart J was the SVP, Clinical Affair of Biomarin Pharmaceutical Inc. (stock ticker symbol BMRN).
Also see all insider trading activities at Biomarin Pharmaceutical Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2008 | BMRN | 0 | $0 | 40,000 | $1,326,612 | 40,000 | $245,200 |
2007 | BMRN | 0 | $0 | 50,000 | $960,587 | 50,000 | $213,312 |
2006 | BMRN | 0 | $0 | 35,000 | $493,632 | 35,000 | $140,000 |
2005 | BMRN | 0 | $0 | 30,000 | $300,000 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2008-07-01 | BMRN | Option Ex | 15,000 | 6.13 | 91,950 |
2008-07-01 | BMRN | Sale | 15,000 | 28.34 | 425,175 |
2008-04-01 | BMRN | Option Ex | 12,500 | 6.13 | 76,625 |
2008-04-01 | BMRN | Sale | 12,500 | 35.95 | 449,400 |
2008-01-02 | BMRN | Sale | 12,500 | 36.16 | 452,037 |
2008-01-02 | BMRN | Option Ex | 12,500 | 6.13 | 76,625 |
2007-10-01 | BMRN | Option Ex | 12,500 | 5.07 | 63,312 |
2007-10-01 | BMRN | Sale | 12,500 | 25.07 | 313,400 |
2007-07-02 | BMRN | Option Ex | 12,500 | 4.00 | 50,000 |
2007-07-02 | BMRN | Sale | 12,500 | 18.18 | 227,250 |
2007-04-02 | BMRN | Sale | 12,500 | 17.30 | 216,237 |
2007-04-02 | BMRN | Option Ex | 12,500 | 4.00 | 50,000 |
2007-01-03 | BMRN | Option Ex | 12,500 | 4.00 | 50,000 |
2007-01-03 | BMRN | Sale | 12,500 | 16.30 | 203,700 |
2006-11-01 | BMRN | Option Ex | 12,500 | 4.00 | 50,000 |
2006-11-01 | BMRN | Sale | 12,500 | 15.92 | 198,975 |
2006-08-01 | BMRN | Sale | 12,500 | 14.34 | 179,187 |
2006-08-01 | BMRN | Option Ex | 12,500 | 4.00 | 50,000 |
2006-02-01 | BMRN | Option Ex | 10,000 | 4.00 | 40,000 |
2006-02-01 | BMRN | Sale | 10,000 | 11.55 | 115,470 |
2005-11-21 | BMRN | Sale | 30,000 | 10.00 | 300,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Swiedler Stuart J (SVP, Clinical Affair of Biomarin Pharmaceutical Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.